字节跳动旗下药物研发部门Anew Labs现已在全球会议上展示AI设计的疗法。该部门在上海、新加坡和圣何塞设有分支机构，并已展示了用于治疗自身免疫性疾病的生成式AI疗法。此举标志着字节跳动正式进军AI驱动的药物研发领域，与阿里巴巴和腾讯等其他中国科技巨头一同加入医疗AI行业。 AI
影响 预示着AI在制药研发中的整合日益加深，有可能加速药物发现的进程。
排序理由 药物研发部门在国际会议上展示了AI设计的疗法。
在 Mastodon — mastodon.social 阅读 →
AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →
ByteDance's drug discovery unit Anew Labs has begun presenting AI-designed therapies at international conferences. The unit, operating from Shanghai, Singapore and San Jose, showcased a generative AI treatment for autoimmune diseases at Immunology2026 in Boston. It four pipeline …
ByteDance's drug discovery unit Anew Labs has presented AI-designed therapies at international conferences. The unit operates from Shanghai, Singapore and San Jose, California, marking the Chinese owner's expansion into AI-powered drug development. ByteDance joins rivals Alibaba …